Al technical title is built by PatSnap Al team. It summarizes the technical point description of the patent document.
A composition and drug technology, applied in the field of pharmaceutical compositions for the treatment of epilepsy, can solve problems such as weight loss, influence on cognition, etc., and achieve the effects of improving symptoms, promoting awakening, and good curative effect
Active Publication Date: 2021-08-24
TEACHING HOSPITAL OF CHENGDU UNIV OF T C M
View PDF5 Cites 0 Cited by
Summary
Abstract
Description
Claims
Application Information
AI Technical Summary
This helps you quickly interpret patents by identifying the three key elements:
Problems solved by technology
Method used
Benefits of technology
Problems solved by technology
The side effects of new antiepileptic drugs have been significantly reduced, but there are still many side effects, such as oxcarbazepine still has serious adverse reactions such as exfoliative dermatitis, topiramate affects cognition and causes weight loss, and the common side effect of lamotrigine is skin rash, etc.
Method used
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more
Image
Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
Click on the blue label to locate the original text in one second.
Reading with bidirectional positioning of images and text.
Smart Image
Examples
Experimental program
Comparison scheme
Effect test
Embodiment 1
[0021] Embodiment 1, the preparation of medicine of the present invention
[0023] Preparation method: take the above-mentioned herbs, add water to decoct, decoct twice in total, add 12 times v / w, ml / g of raw medicinal materials for decoction each time, and decoct for 2 hours, combine the two decoction liquids to obtain the product.
Embodiment 2
[0024] Embodiment 2, the preparation of medicine of the present invention
[0026] Preparation method: take the above-mentioned herbs, add water to decoct, decoct 3 times in total, add 6 times the amount of raw medicinal materials v / w, ml / g each time and decoct for 1 hour, combine the two decoction liquids to obtain the product.
Embodiment 3
[0027] Embodiment 3, the preparation of medicine of the present invention
[0029] Preparation method: take the above-mentioned herbs, add water to decoct, decoct twice in total, each time add 8 times the amount of raw medicinal materials v / w, ml / g to decoct for 1.5 hours, combine the two decoction liquids to obtain the product.
[0030] The beneficial effects of the present invention are illustrated below through test examples.
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
PUM
Login to view more
Abstract
The invention discloses a pharmaceutical composition for treating epilepsy. The pharmaceutical composition is prepared from the following raw materials in parts by weight: 10-20 parts of radix bupleuri, 14-26 parts of rhizoma acori graminei, 21-39 parts of uncaria, 21-39 parts of fossil fragments, 21-39 parts of oyster, 21-39 parts of white paeony root, 7-13 parts of divaricate saposhnikovia root, 10-20 parts of fried stiff silkworm, 10-20 parts of earthworm and 3-7 parts of liquorice. The composition disclosed by the invention has a remarkable effect on treating epilepsy, also has the effects of improving symptoms and reducing or controlling attack on part of intractable epilepsy, and can play a synergistic effect with anti-epilepsy western medicines when being used for an epileptic state, and meanwhile, can promote a patient to wake up. Compared with western medicines, the composition disclosed by the invention is safer, has no obvious toxic and side effects in long-term clinical application, has no side effects such as cognitive impairment, language impairment, dizziness and the like, has no teratogenesis effect, and has a clinical application prospect.
Description
technical field [0001] The invention specifically relates to a pharmaceutical composition for treating epilepsy. Background technique [0002] Epilepsy, commonly known as "shorn wind" or "epilepsy", is a recurrent chronic disease that requires long-term medication. Common antiepileptic drugs have many side effects, including gastrointestinal reactions and dizziness. , headache, drowsiness, double vision, ataxia of physical activity, etc., such as valproic acid side effects include weight gain, chronic cognition, memory, behavior changes, a few have severe liver toxicity, pancreatitis may occur, drugs There are obvious interactions between phenobarbital, chronic tissue and cognitive toxicity, and teratogenic effects; phenobarbital has sedative side effects, occasionally can cause connective tissue damage, withdrawal reactions, and teratogenic effects; ethosuximide occasionally has gastrointestinal reactions ; The initial dose of carbamazepine is prone to neurotoxicity, has m...
Claims
the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more
Application Information
Patent Timeline
Application Date:The date an application was filed.
Publication Date:The date a patent or application was officially published.
First Publication Date:The earliest publication date of a patent with the same application number.
Issue Date:Publication date of the patent grant document.
PCT Entry Date:The Entry date of PCT National Phase.
Estimated Expiry Date:The statutory expiry date of a patent right according to the Patent Law, and it is the longest term of protection that the patent right can achieve without the termination of the patent right due to other reasons(Term extension factor has been taken into account ).
Invalid Date:Actual expiry date is based on effective date or publication date of legal transaction data of invalid patent.
Login to view more 
Login to view more